| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0967-5868(96)90083-1 |
| P698 | PubMed publication ID | 18644264 |
| P50 | author | Glenda Halliday | Q45304807 |
| P2093 | author name string | J G Morris | |
| D A McRitchie | |||
| R Pamphlett | |||
| M A Hely | |||
| H Cartwright | |||
| P2860 | cites work | Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. | Q52031965 |
| Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human | Q59544709 | ||
| A Population-Based Investigation of Parkinson's Disease With and Without Dementia | Q61881968 | ||
| Age-induced cognitive disturbances in Parkinson's disease | Q68694928 | ||
| A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle | Q72136531 | ||
| Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls | Q72286058 | ||
| Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey | Q72625382 | ||
| Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease | Q28324372 | ||
| Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method | Q33589165 | ||
| Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease | Q33631371 | ||
| The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa | Q33732870 | ||
| A clinicopathologic study of 100 cases of Parkinson's disease | Q36776426 | ||
| Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease | Q36947501 | ||
| The brain-stem lesions in Parkinsonism | Q37272987 | ||
| Diffuse Lewy body disease in Japan | Q37941288 | ||
| Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism | Q39111952 | ||
| Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions | Q39111957 | ||
| Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels | Q39113010 | ||
| Quantitative changes in some subcortical nuclei in aging, Alzheimer's disease and Parkinson's disease | Q39691524 | ||
| Analysis of staining methods for different cortical plaques in Alzheimer's disease | Q41056808 | ||
| Nigrostriatal function in humans studied with positron emission tomography | Q41263099 | ||
| Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease | Q41346993 | ||
| Rate of cell death in parkinsonism indicates active neuropathological process | Q41417978 | ||
| Striatal dopamine deficiency in Parkinson's disease: role of aging | Q41993839 | ||
| Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease | Q44491341 | ||
| Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra | Q45020106 | ||
| Alzheimer's disease and Lewy body disease: a comparative clinicopathological study | Q48196630 | ||
| Aging of the nigrostriatal pathway in humans | Q48222022 | ||
| Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins | Q48289141 | ||
| Comparison of modified Bielschowsky silver impregnation and anti‐ubiquitin immunostaining of cortical and nigral Lewy bodies | Q48404877 | ||
| The neuropathologic basis of different clinical subgroups of Parkinson's disease | Q48633612 | ||
| Striatal function in normal aging: implications for Parkinson's disease | Q48849323 | ||
| P433 | issue | 1 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 52-60 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Journal of Clinical Neuroscience | Q6294963 |
| P1476 | title | Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease | |
| P478 | volume | 3 |
| Q36949813 | Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects |
| Q35046915 | An inflammatory review of Parkinson's disease. |
| Q42519458 | Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei |
| Q37043102 | Disease duration and the integrity of the nigrostriatal system in Parkinson's disease |
| Q46764881 | Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle |
| Q44579210 | Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine. |
| Q37587790 | Formation and development of Lewy pathology: a critical update |
| Q48707835 | Further evidence for an association between a mutation in the APP gene and Lewy body formation |
| Q48709665 | GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. |
| Q34802086 | Influence of neuromelanin on oxidative pathways within the human substantia nigra |
| Q36673364 | Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking |
| Q36626757 | Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease |
| Q64785437 | Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease |
| Q38310102 | Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update |
| Q43564955 | Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease |
| Q41718471 | Neuropathology of movement disorders. |
| Q55450592 | Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway. |
| Q55432445 | On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. |
| Q47314960 | Parkinson's Disease Is Not Simply a Prion Disorder |
| Q44365334 | Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. |
| Q39095738 | Selective neuronal vulnerability in Parkinson disease |
| Q39108546 | The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy |
| Q89769611 | The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review |
| Q53841253 | The concept of alpha-synuclein as a prion-like protein: ten years after. |
| Q48263048 | The midbrain dopaminergic cell groups in the baboon Papio ursinus |
| Q36568001 | The mystery of motor asymmetry in Parkinson's disease |
| Q52719394 | The role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: a locomotor analysis. |
| Q39215309 | Three-dimensional and stereological characterization of the human substantia nigra during aging |
| Q37589838 | Voxelwise meta-analysis of gray matter anomalies in progressive supranuclear palsy and Parkinson's disease using anatomic likelihood estimation |
| Q35551615 | β-Amyloid and α-synuclein cooperate to block SNARE-dependent vesicle fusion |
Search more.